Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Investor Presentation

25 Mar 2022 10:45

RNS Number : 0679G
Ebiquity PLC
25 March 2022
 

Ebiquity Plc

25 March 2022

 

Investor Presentation

Ebiquity plc is pleased to announce that Nick Waters and Alan Newman will provide a live presentation on its Full Year Results via the Investor Meet Company platform on 31 March 2022 at 15:00 BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted in advance via your Investor Meet Company dashboard up until 09:00 BST the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Ebiquity plc via:

https://www.investormeetcompany.com/ebiquity-plc/register-investor

Investors who already follow Ebiquity plc on the Investor Meet Company platform will automatically be invited. 

 Enquiries: 

 

Ebiquity plc

+44 20 7650 9600

Nick Waters, CEO

Alan Newman, CFO & COO

Camarco

Ben Woodford

+44 7990 653 341

Geoffrey Pelham-Lane

+44 7733 124 226

Panmure Gordon (Financial Adviser, Nomad and Broker)

+44 20 7886 2500

Alina Vaskina (Corporate Advisory)

Charles Leigh-Pemberton (Corporate Broking)

 

About Ebiquity plc

 

Ebiquity plc (LSE AIM: EBQ) is a world leader in media investment analysis. It harnesses the power of data to provide independent, fact-based advice, enabling brand owners to perfect media investment decisions and improve business outcomes. Ebiquity is able to provide independent, unbiased advice and solutions to brands because we have no commercial interest in any part of the media supply chain.

 

We are a data-driven solutions company helping brand owners drive efficiency and effectiveness from their media spend, eliminating wastage and creating value. We provide analysis and solutions through five Service Lines: Media management, Media performance, Marketing effectiveness, Technology advisory, Contract compliance.

 

Ebiquity's clients are served by more than 500 media specialists operating from 19 offices covering 80% of the global advertising market.

 

The Company has the most comprehensive, independent view of today's global media market, analysing $55bn of media spend from 75 markets annually, including trillions of digital media impressions. Our Contract Compliance division, FirmDecisions, audits $40bn of contract value annually.

 

As a result, more than 70 of the world's top 100 advertisers today choose Ebiquity as their trusted independent media advisor.

 

For further information, please visit: www.ebiquity.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEDFSIEESELD
Date   Source Headline
11th Mar 20152:16 pmRNSExercise of Share Options
26th Feb 20152:14 pmRNSAcquisition of Media Value
16th Feb 201512:45 pmRNSExercise of Share Options
13th Feb 20153:50 pmRNSAcquisition and issue of shares
6th Feb 201510:34 amRNSDirector/PDMR Shareholding
4th Feb 20155:00 pmRNSHolding(s) in Company
2nd Feb 20152:55 pmRNSHolding(s) in Company
28th Jan 20157:00 amRNSInterim Results
19th Jan 20158:45 amRNSExercise of Share Options
8th Jan 20154:28 pmRNSHolding(s) in Company
27th Nov 20147:00 amRNSExercise of Share Options
24th Nov 20143:00 pmRNSDirector Dealing
24th Nov 20142:59 pmRNSHolding(s) in Company
24th Nov 20142:55 pmRNSDirector Dealing and Exercise of Share Options
21st Nov 20147:00 amRNSAppointment of Non-Executive Directors
21st Nov 20147:00 amRNSTrading update
14th Nov 20143:22 pmRNSDirector Dealing
11th Nov 20149:10 amRNSDirector Dealing
10th Sep 201411:57 amRNSResult of AGM
6th Aug 20147:00 amRNSAnnual Report
31st Jul 20143:49 pmRNSHolding(s) in Company
16th Jul 20147:00 amRNSFinal Results
3rd Jul 20147:00 amRNSNew Debt Facility
13th Jun 20148:30 amRNSAppointment of MD, South East Asia
16th May 201411:33 amRNSAward of share options
8th May 20147:00 amRNSAcquisition
14th Apr 20147:00 amRNSAppointment of CEO, Americas
7th Apr 20147:00 amRNSPayment of deferred consideration
19th Mar 20147:00 amRNSChange of Registered Office
13th Mar 20143:05 pmRNSHolding(s) in Company
11th Mar 20145:32 pmRNSExercise of Share Options
7th Mar 20141:04 pmRNSExercise of Share Options
7th Mar 20147:00 amRNSDirectors' dealings and directorate changes
6th Mar 20147:00 amRNSDirectorate
3rd Mar 201412:02 pmRNSHolding(s) in Company
21st Feb 20149:32 amRNSHolding(s) in Company
20th Feb 20145:45 pmRNSHolding in Company / Issue of Equity
13th Feb 201411:00 amRNSHolding in Company / Issue of Equity
13th Feb 201410:24 amRNSHolding(s) in Company
12th Feb 201410:34 amRNSHolding(s) in Company
7th Feb 201412:50 pmRNSHolding(s) in Company
7th Feb 201412:10 pmRNSHolding(s) in Company
6th Feb 201412:02 pmRNSHolding(s) in Company
5th Feb 20144:49 pmRNSHolding(s) in Company
22nd Jan 20145:34 pmRNSExercise of Share Options
21st Jan 20144:06 pmRNSExercise of Share Options
17th Jan 20144:24 pmRNSDirector/PDMR Shareholding
15th Jan 20147:00 amRNSInterim Results
15th Jan 20147:00 amRNSAcquisition
15th Jan 20147:00 amRNSConclusion of Review of Strategic Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.